March 20, 2017 / 12:49 PM / 4 months ago

BRIEF-Ampio pharmaceuticals provides corporate update

1 Min Read

March 20 (Reuters) - Ampio Pharmaceuticals Inc

* Ampio pharmaceuticals provides corporate update

* Ampio pharmaceuticals - plans to advance all necessary biologic license application activities in parallel to expedite path to potential FDA approval

* Board of directors has selected locust walk to serve as a strategic advisor to company

* Locust Walk's charter will be to identify and evaluate potential strategic relationships for Ampion Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below